Gabriel A Silva

Prof. Gabriel A Silva


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2004 in Science
Verified
Journal Article
Closed access
PDF file
Gabriel A SilvaGabriel A Silva
Gabriel A Silva
CCCatherine Czeisler
Catherine Czeisler
KNKrista L. Niece
Krista L. Niece
EBElia Beniash
Elia Beniash
DHDaniel Harrington
Daniel Harrington
SSSamuel I. Stupp
Samuel I. Stupp
Neural progenitor cells were encapsulated in vitro within a three-dimensional network of nanofibers formed by self-assembly of peptide amphiphile molecules. The self-assembly is triggered by mixing cell suspensions in media with dilute aqueous solutions of the molecules, and cells survive the growth of the nanofibers around them. These nanofibers were designed to present to cells the neurite-promoting laminin epitope IKVAV at nearly van der Waals density. Relative to laminin or soluble peptide, the artificial nanofiber scaffold induced very rapid differentiation of cells into neurons, while discouraging the development of astrocytes. This rapid selective differentiation is linked to the amplification of bioactive epitope presentation to cells by the nanofibers.

16 October 2009 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
NKNicholas A. Kotov
Nicholas A. Kotov
JWJessica Winter
Jessica Winter
ICIsaac P. Clements
Isaac P. Clements
EJEdward Jan
Edward Jan
BTBrian P. Timko
Brian P. Timko
LBLaura Ballerini
Laura Ballerini

1 January 2006 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
Gabriel A SilvaGabriel A Silva
Gabriel A Silva

15 February 2006 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SPSmita Pathak
Smita Pathak
ECElizabeth Cao
Elizabeth Cao
MDMarie C. Davidson
Marie C. Davidson
SJSungho Jin
Sungho Jin
Gabriel A SilvaGabriel A Silva
Gabriel A Silva
Editor’s Note: Toolboxes are a new, occasional feature in the Journal designed to briefly highlight a new method or a resource of general use in neuroscience or to critically analyze existing approaches or methods. For more information, see .

10 December 2008 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
Gabriel A SilvaGabriel A Silva
Gabriel A Silva
Nanotechnologies are materials and devices that have a functional organization in at least one dimension on the nanometer (one billionth of a meter) scale, ranging from a few to about 100 nanometers. Nanoengineered materials and devices aimed at biologic applications and medicine in general, and neuroscience in particular, are designed fundamentally to interface and interact with cells and their tissues at the molecular level. One particularly important area of nanotechnology application to the central nervous system (CNS) is the development of technologies and approaches for delivering drugs and other small molecules such as genes, oligonucleotides, and contrast agents across the blood brain barrier (BBB). The BBB protects and isolates CNS structures (i.e. the brain and spinal cord) from the rest of the body, and creates a unique biochemical and immunological environment. Clinically, there are a number of scenarios where drugs or other small molecules need to gain access to the CNS following systemic administration, which necessitates being able to cross the BBB. Nanotechnologies can potentially be designed to carry out multiple specific functions at once or in a predefined sequence, an important requirement for the clinically successful delivery and use of drugs and other molecules to the CNS, and as such have a unique advantage over other complimentary technologies and methods. This brief review introduces emerging work in this area and summarizes a number of example applications to CNS cancers, gene therapy, and analgesia.